Travere Therapeutics, Inc.

TVTX

$66.09

-0.68%

2026-09-04 10:02:17 EDT-$0.45

Healthcare

Biotechnology

NASDAQ

Negociación activa

Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies for rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an ...

Transacciones de insiders de TVTX

Compras (A)

Since Jun 22, 2026

Ventas (D)

Since Jun 22, 2026

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Sep 2, 2026	Cline Christopher R.	officer: CHIEF FINANCIAL OFFICER	Common Stock	D	642	$66.37
Aug 18, 2026	LYONS GARY A	director	Common Stock	A	5,000	$17.44
Aug 18, 2026	LYONS GARY A	director	Common Stock	D	4,100	$63.27
Aug 18, 2026	LYONS GARY A	director	Common Stock	D	900	$63.86
Aug 18, 2026	LYONS GARY A	director	Stock option (right to buy)	D	5,000	$17.44

Resumen de trading de insiders

Compras (A)

Ventas (D)

Acciones compradas totales

5,000

Acciones vendidas totales

21,110

Actividad mensual de insiders

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Por cargo - Acciones

Eje X: acciones, ordenado por acciones totales desc.

Por cargo - Conteos

Eje X: conteos, ordenado por conteos A+D desc.

Personas clave: actividad de compra/venta y precio

LYONS GARY A

director • 8 transacciones

Cline Christopher R.

officer: CHIEF FINANCIAL OFFICER • 1 transacciones

Inrig Jula

officer: CHIEF MEDICAL OFFICER • 1 transacciones

Tabla de transacciones

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio	Valor
Sep 2, 2026	Cline Christopher R.	officer: CHIEF FINANCIAL OFFICER	Common Stock	D	642	$66.37	$42,609.54
Aug 18, 2026	LYONS GARY A	director	Common Stock	A	5,000	$17.44	$87,200.00
Aug 18, 2026	LYONS GARY A	director	Common Stock	D	4,100	$63.27	$259,390.19
Aug 18, 2026	LYONS GARY A	director	Common Stock	D	900	$63.86	$57,470.13
Aug 18, 2026	LYONS GARY A	director	Stock option (right to buy)	D	5,000	$17.44	$87,200.00
Aug 17, 2026	LYONS GARY A	director	Common Stock	D	1,900	$62.53	$118,804.91
Aug 17, 2026	LYONS GARY A	director	Common Stock	D	2,600	$63.50	$165,099.74
Aug 17, 2026	LYONS GARY A	director	Common Stock	D	500	$64.16	$32,081.00
Aug 17, 2026	LYONS GARY A	director	Stock option (right to buy)	D	5,000	$17.44	$87,200.00
Jun 22, 2026	Inrig Jula	officer: CHIEF MEDICAL OFFICER	Common Stock	D	468	—	—

Supply Chain de TVTX

RELATIONS

Upstream

Catalent Pharma Solutions, LLCNYSE:CTLTSTA Pharmaceutical Hong Kong Limited / WuXi AppTecSHA:603259Mission Pharmacal CompanyLigand Pharmaceuticals IncorporatedNASDAQ:LGNDEverest Medicines LimitedHKEx:1952.HKUnidentified specialty chemical and excipient suppliers

Downstream

CSL Vifor / CSL LimitedASX:CSLChugai Pharmaceutical Co., Ltd. (via Renalys Pharma acquisition)TSE:4519Optum Frontier Therapies / OptumRx (UnitedHealth Group)NYSE:UNH CVS Specialty / CVS Caremark (CVS Health)NYSE:CVS Accredo Specialty Pharmacy / Express Scripts (Cigna Group)NYSE:CI

Proxies

Ligand Pharmaceuticals IncorporatedNASDAQ:LGNDCSL LimitedASX:CSLMirum Pharmaceuticals, Inc.NASDAQ:MIRM

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal